10 employees
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy.
2010
$850K
from 2 investors over 2 rounds
Tansna Therapeutics Inc. raised $850K on February 26, 2014
Investors: iSelect Fund
Tansna Therapeutics Inc. raised undisclosed on September 20, 2013